Skip to main content
. 2020 Jul 10;9(7):397. doi: 10.3390/antibiotics9070397
AMR antimicrobial resistance
ATF ambient temperature fimbria
BIA biolayer interferometry assay
CAUTIs catheter-associated UTIs
CBD carbohydrate binding domain
CBS carbohydrate-binding site
CD-based HMs cyclodextrin-based heptyl mannosides
CTD C-terminal domain
CU chaperon-usher
DSF differential scanning fluorimetry
ECDC European Center of Diseases Prevention and Control
ELISA enzyme-linked immuno sorbent assay
Fim3 Fimbria 3
FPA fluorescence polarization assay
IBCs intracellular bacterial communities
ITC isothermal titration calorimetry
MBP mannose-binding pocket
MBS mannose-binding site
MDR multi-drug-resistant
MeMan Methyl α-d-mannoside
MR/P mannose-resistant Proteus-like
MR/K mannose-resistant Klebsiella-like
NAF non-agglutinating fimbria
NTD N-terminal domain
PACs proanthocyanidins
pap pyelonephritis-associated pili
PDR pan-drug-resistant
PMF P. mirabilis fimbria
PMP P. mirabilis P-like pili
RIP relative inhibitory potency
RLA radioactive labeling assay
rUTI recurrent UTI
SPR surface plasmon resonance
UCA urothelial cell adhesin
UTI urinary tract infection
UPEC uropathogenic Escherichia coli
UPKP uropathogenic Klebsiella pneumoniae
UPPM uropathogenic Proteus mirabilis
UPs uroplakins